Scholarly publications and presentations by Rochester Regional Health's Allergy and Immunology department authors.

Follow


Submissions from 2022

Link

5-1-2022          Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine, S. Shahzad Mustafa, Rochester Regional Health; Sara Patrawala; and Sandhya Khurana

4-12-2022          Practical Approach to Urticaria with Angioedema, Denise Sanchez Tejera, Rochester Regional Health

Link

4-2022          Mise en place de l’immunothérapie orale pour l’allergie à l’arachide en pratique clinique aux États-Unis : huit conseils, S. Shahzad Mustafa, Rochester Regional Health and R Montagne, Aimmune Therapeutics

Link

4-1-2022          Real World Adoption of FDA-approved Peanut Oral Immunotherapy with Palforzia, Sara Patrawala, University of Rochester School of Medicine and Dentistry, Rochester NY., Allison Ramsey, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, et al.

Link

4-2022          Standardisation de la poudre de graine d’Arachis hypogaea L. (arachide) allégée en graisses (PDAH) pour une immunothérapie orale : test des lots de matériel source, S A. Leonard, University of California San Diego; R Montagne, Aimmune Therapeutics; and S. Shahzad Mustafa, Rochester Regional Health

Link

3-2022          Anaphylaxis knowledge gaps and future research priorities: A consensus report, Timothy E. Dribin, Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., David Schnadower, Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., Julie Wang, Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY., et al.

Link

2-1-2022          Cephalexin, Cefaclor, and Ampicillin: Points in the Picture of β-Lactam Cross-Reactivity, Allison Ramsey, Rochester Regional Health

Link

2-1-2022          The United States Drug Allergy Registry: A Prospective Longitudinal Cohort Study of Patients Tested for Drug Allergies, Kimberly Blumenthal, Allison Ramsey, Rochester Regional Health, S. Shahzad Mustafa, Rochester Regional Health, et al.

1-18-2022          COVID-19: Medication Update, Anja Bottler, Rochester Regional Health and S Shahzad Mustafa, Rochester Regional Health

File

1-6-2022          COVID, Emil P. Lesho, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Maryrose Laguio-Vila, Rochester Regional Health

Submissions from 2021

Link

12-1-2021          Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose, Linh-An C. Tuong, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, Mary Staicu, Rochester Regional Health, et al.

Link

10-15-2021          Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia, S Shahzad Mustafa, Rochester Regional Health, Saad Jamshed, Rochester Regional Health, Karthik Vadamalai, Division of Critical Care, Mercy Hospital, Springfield, Missouri, United States of America., et al.

Link

8-20-2021          CLL Society's Official Statement on Boosters for Cll (Chronic Lymphocytic Leukemia) Patients, Brian Koffman; Alan Z. Skarbnik; and S. Shahzad Mustafa, Rochester Regional Health

8-10-2021          Drug Allergy Management on the Move, Pascal Demoly, Division of Allergy, Department of Pulmonology, University Hospital of Montpellier, Montpellier, France; IDESP UA11 INSERM-Univ Montpellier, Montpellier, France. and Allison Ramsey, Rochester Regional Health

Link

6-22-2021          The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach, Matthew Greenhawt, Section of Allergy and Clinical Immunology, Food Challenge and Research Unit, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo., Elissa M. Abrams, Department of Pediatrics and Child Health, Section of Allergy and Immunology, The University of Manitoba, Winnipeg, Man, Canada., Marcus Shaker, Dartmouth-Hitchcock Medical Center, Section of Allergy and Immunology, Lebanon; Dartmouth Geisel School of Medicine, Hanover, NH., et al.

Link

6-2021          Dupilumab Increases Aspirin Tolerance in Aspirin-Exacerbated Respiratory Disease, S Shahzad Mustafa, Rochester Regional Health and Karthik Vadamalai, Mercy Hospital, Springfield, Mo.

Link

5-16-2021          Differences in Oral Food Challenge Reaction Severity Based on Increasing Age in a Pediatric Population, Katie Kennedy, Children's Hospital of Philadelphia, Philadelphia, PA, Maria Katerina C. Alfaro, Children's Hospital of Philadelphia, Philadelphia, PA, Zachary C. Spergel, University of Rochester, Rochester, NY, et al.

Link

5-2021          Patient Satisfaction with In-Person, Video, and Telephone Allergy/Immunology Evaluations During the COVID-19 Pandemic, S. Shahzad Mustafa, Rochester Regional Health; Karthik Vadamalai, Mercy Hospital, Springfield, Mo.; and Allison Ramsey, Rochester Regional Health

Link

5-1-2021          Prevention and management of allergic reactions to food in child care centers and schools: Practice guidelines, Susan Waserman, McMaster University, Heather Cruickshank, McMaster University, Kyla J. Hildebrand, The University of British Columbia, et al.

Link

4-23-2021          Rheumatology Patient Satisfaction With Telemedicine During the COVID-19 Pandemic in the United States, Mahta Mortezavi, Rochester Regional Health, Sravani Lokineni, Rochester Regional Health, Megha Garg, Rochester Regional Health, et al.

Link

4-6-2021          Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports [letter], S Shahzad Mustafa, Rochester Regional Health; Allison Ramsey, Rochester Regional Health; and Mary L. Staicu, Rochester Regional Health

Link

4-5-2021          Adult Peanut Allergy, What We Know and What We Need to Learn, Soheila J. Maleki, United States Department of Agriculture, Agricultural Research Service; Suzanne S. Teuber, UC Davis School of Medicine; and S Shahzad Mustafa, Rochester Regional Health

Link

4-1-2021          Examining the impact of a penicillin allergy skin testing brochure on inpatient perceptions: A pre-post intervention study, Mikaela Brown, St. John Fisher College, Joy Uzoma, St. John Fisher College, Ryan Vansice, St. John Fisher College, et al.

Link

4-1-2021          Paediatric Allergy Practice in the Era of Coronavirus Disease 2019, S. Shahzad Mustafa, Rochester Regional Health, Marcus S. Shaker, Dartmouth-Hitchcock Medical Center, Daniel Munblit, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom, et al.

Link

2-16-2021          Drug Allergy Labels Lost in Translation: From Patient to Charts and Backwards, Allison Ramsey, Rochester Regional Health, Eric Macy, Kaiser Permanente Southern California, San Diego, Calif., Anca-Mirela Chiriac, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France, et al.